Research field (3)：
Immunology
, Medical biochemistry
, Pharmacology
Research keywords (3)：
Immunology
, Pharmacology
, Biochemistry
Research theme for competitive and other funds (2)：
Hypoxia Signaling Pathway
Molecular Mechanism of TCDD-induced thymic atrophy
Papers (36)：
Shimokawa T, Yoneda K, Yamagata M, Hayashi K, Tomita S. Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats. European journal of pharmacology. 2020. 871. 172917
Matsunaga S, Tomita S. [The effect of PHD inhibitor on tumor microenvironment and tumor immune response]. 公益社団法人 日本薬理学会 Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2020. 155. 1. 35-39
Takeda N, Tomita S. [Preface]. 公益社団法人 日本薬理学会 Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2020. 155. 1. 25-25
Kabei K, Tateishi Y, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Matsunaga S, Yamaguchi T, Tomita S, Miura K. Effects of orally active hypoxia inducible factor alpha prolyl hydroxylase inhibitor, FG4592 on renal fibrogenic potential in mouse unilateral ureteral obstruction model. Journal of pharmacological sciences. 2019
Shunji Nishide, Shinji Matsunaga, Masayuki Shiota, Takehiro Yamaguchi, Shojiro Kitajima, Yoichi Maekawa, Norihiko Takeda, Michio Tomura, Junji Uchida, Katsuyuki Miura, Tatsuya Nakatani, Shuhei Tomita. Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model. iScience. 2019. 21. 205-205
